ExpreS2ion Biotech Holding AB (publ)

Research ExpreS2ion Biotech Holding AB (publ) (5JD0) on Bullrun: market cap EUR 375.56K. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker5JD0
• ExchangeF
• CountrySweden
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 375.56K
• Financial periodQ4 2025
• RevenueEUR 435.00K
• Net income-EUR 8.18M
• Free cash flowEUR 684.00K
• Gross margin-93.8%

Valuation Snapshot

latest market cap is EUR 375.56K.

About ExpreS2ion Biotech Holding AB (publ)

ExpreS2ion Biotech Holding AB (publ), a biotechnology company, develops protein based immunotherapies and vaccines for oncology and infectious diseases in the Nordics and internationally. The company's lead asset is ES2B-C001, a therapeutic vaccine which is in Phase 1 clinical trials for breast cancer that targets the human epidermal growth factor receptor 2, as well as vaccines for Nipah virus, Malaria, and influenza.

Frequently asked questions

What is ExpreS2ion Biotech Holding AB (publ)'s market cap?

ExpreS2ion Biotech Holding AB (publ)'s market capitalization is EUR 375.56K.

What does ExpreS2ion Biotech Holding AB (publ) do?

ExpreS2ion Biotech Holding AB (publ), a biotechnology company, develops protein based immunotherapies and vaccines for oncology and infectious diseases in the Nordics and internationally.